Number of Abnormal Tests/Total Number of Tests (%) | Â | Spontaneous High Frequency Motor Unit Action Potentials | Repetitive Compound Motor Action Potentials |
---|---|---|---|
Before | Patients | 0/8 (0%) | 1/8 (13%) |
Oxaliplatin | Muscles or Nerves | 0/32 (0%) | 1/32 (3.2%) |
After Oxaliplatin | Patients | 6/6 (100%) | 5/7 (71%) |
(Days 2-4) | Muscles or Nerves | 16/22 (72%) | 9/28 (32%) |
After Oxaliplatin | Patients | 2/8 (25%) | 2/8 (25%) |
(Days 14-20) | Muscles or Nerves | 4/32 (12%) | 3/31 (10%) |
After Other | Patients | 0/6 (0%) | 1/6 (17%) |
Platinum Drug (Days 2-4) | Muscles or Nerves | 0/24 (0%) | 2/24 (8%) |
Sensitivity* | Patients | 100% | 71% |
 | Muscles or Nerves | 72% | 32% |
Specificity* | Patients | 100% | 86% |
 | Muscles or Nerves | 100% | 95% |